ABSTRACT
Inflammatory bowel disease lacks a long-lasting and broadly effective therapy. Here, by taking advantage of the anti-infection and anti-inflammatory properties of natural antibodies against the small-molecule epitope phosphorylcholine (PC), we show in multiple mouse models of colitis that immunization of the animals with self-assembling supramolecular peptide nanofibres bearing PC epitopes induced sustained levels of anti-PC antibodies that were both protective and therapeutic. The strength and type of immune responses elicited by the nanofibres could be controlled through the relative valency of PC epitopes and exogenous T-cell epitopes on the nanofibres and via the addition of the adjuvant CpG. The nanomaterial-assisted induction of the production of therapeutic antibodies may represent a durable therapy for inflammatory bowel disease.
ABSTRACT
Angiogenesis after stroke is correlated with enhanced tissue repair and functional outcomes. The existing body of research in biomaterials for stroke focuses on hydrogels for the delivery of stem cells, growth factors, or small molecules or drugs. Despite the ability of hydrogels to enhance all these delivery methods, no material has significantly regrown vasculature within the translatable timeline of days to weeks after stroke. Here, two novel biomaterial formulations of granular hydrogels are developed for tissue regeneration after stroke: highly porous microgels (i.e., Cryo microgels) and microgels bound with heparin-norbornene nanoparticles with covalently bound SDF-1α. The combination of these materials results in perfused vessels throughout the stroke core in only 10 days, in addition to increased neural progenitor cell recruitment, maintenance, and increased neuronal differentiation.
ABSTRACT
Chimeric antigen receptor (CAR) T cell therapy in glioblastoma faces many challenges including insufficient CAR T cell abundance and antigen-negative tumor cells evading targeting. Unfortunately, preclinical studies evaluating CAR T cells in glioblastoma focus on tumor models that express a single antigen, use immunocompromised animals, and/or pre-treat with lymphodepleting agents. While lymphodepletion enhances CAR T cell efficacy, it diminishes the endogenous immune system that has the potential for tumor eradication. Here, we engineered CAR T cells to express IL7 and/or Flt3L in 50% EGFRvIII-positive and -negative orthotopic tumors pre-conditioned with non-lymphodepleting irradiation. IL7 and IL7 Flt3L CAR T cells increased intratumoral CAR T cell abundance seven days after treatment. IL7 co-expression with Flt3L modestly increased conventional dendritic cells as well as the CD103+XCR1+ population known to have migratory and antigen cross-presenting capabilities. Treatment with IL7 or IL7 Flt3L CAR T cells improved overall survival to 67% and 50%, respectively, compared to 9% survival with conventional or Flt3L CAR T cells. We concluded that CAR T cells modified to express IL7 enhanced CAR T cell abundance and improved overall survival in EGFRvIII heterogeneous tumors pre-conditioned with non-lymphodepleting irradiation. Potentially IL7 or IL7 Flt3L CAR T cells can provide new opportunities to combine CAR T cells with other immunotherapies for the treatment of glioblastoma.
Subject(s)
Glioblastoma , Glioma , Animals , Mice , ErbB Receptors , Glioblastoma/therapy , Interleukin-7 , T-LymphocytesABSTRACT
Microgels are the building blocks of microporous annealed particle (MAP) scaffolds, which serve as a platform for both in vitro cell culture and in vivo tissue repair. In these granular scaffolds, the innate porosity generated by the void space between microgels enables cell infiltration and migration. Controlling the void fraction and particle fraction is critical for MAP scaffold design, as porosity is a bioactive cue for cells. Spherical microgels can be generated on a microfluidic device for controlled size and shape and subsequently freeze-dried using methods that prevent fracturing of the polymer network. Upon rehydration, the lyophilized microgels lead to controlled particle fractions in MAP scaffolds. The implementation of these methods for microgel lyophilization has led to reproducible studies showing the effect of particle fraction on macromolecule diffusion and cell spreading. The following protocol will cover the fabrication, lyophilization, and rehydration of microgels for controlling particle fraction in MAP scaffolds, as well as annealing the microgels through bio-orthogonal crosslinking for 3D cell culture in vitro.
Subject(s)
Hydrogels , Microgels , Cell Culture Techniques, Three Dimensional , Porosity , Cell Culture Techniques , Tissue ScaffoldsABSTRACT
Microporous annealed particle (MAP) hydrogels are porous 3D scaffolds generated by interlinking randomly packed microgels (µgels). Particle fraction, hydrogel stiffness, microparticle shape, and crosslinking chemistry are paramount to the microstructure that microgels make within MAP scaffolds. Of these parameters, control over the particle fraction in MAP scaffolds varies greatly by user and drying technique, leading to inconsistent microarchitectures. These inconsistencies have biological ramifications, as the particle fraction of MAP scaffolds determines the void space within the material which strongly impacts cell growth. Here, we describe a method of freeze-drying microgels that leads to consistent and user-defined particle fractions by weighing the dried microgel powder and reconstituting at known volumes. Though freeze-drying hydrogels typically leads to ice crystal and cryogel formation, we report on mediums that result in freeze-dried microgels that retain their original properties when rehydrated. By rehydrating lyophilized microgels to form MAP scaffolds, we demonstrate that particle fraction controls the bulk scaffold stiffness, but not local microgel stiffness. Further, the particle fraction in MAP scaffolds directly affects cell growth and macromolecular diffusion. Using controlled particle fractions in MAP scaffolds, we can now reproducibly assess mechanical properties, diffusion of macromolecules, and cell responses within user-defined microarchitectures. STATEMENT OF SIGNIFICANCE: The porosity of biomaterials is one key characteristic that influences cell infiltration and growth. Granular hydrogels are a class of biomaterials that are comprised of small, building block components that boast a porous architecture in the void space between the particles. Controlling the composition of these granular materials is key to guiding cell responses. In this work, we demonstrate methods for controlling the fraction of the material containing hydrogel versus void space. As a result, we can now reproducibly study the effect of particle fraction on cell responses, mechanical properties, and mass transport in granular hydrogels.
Subject(s)
Microgels , Tissue Scaffolds , Biocompatible Materials , Cues , Hydrogels/chemistry , Tissue Scaffolds/chemistryABSTRACT
Macroporous scaffolds are being increasingly used in regenerative medicine and tissue repair. While the recently developed microporous annealed particle (MAP) scaffolds have overcome issues with injectability and in situ hydrogel formation, limitations with respect to tunability to be able to manipulate hydrogel strength and rigidity for broad applications still exist. To address these key issues, here hydrogel microparticles (HMPs) of hyaluronic acid (HA) are synthesized using the thiol-norbornene click reaction and then HMPs are subsequently annealed into a porous scaffold using the tetrazine-norbornene click reaction. This assembly method allows for straightforward tuning of bulk scaffold rigidity by varying the tetrazine to norbornene ratio, with increasing tetrazine resulting in increasing scaffold storage modulus, Young's modulus, and maximum stress. These changes are independent of void fraction. Further incorporation of human dermal fibroblasts throughout the porous scaffold reveals the biocompatibility of this annealing strategy as well as differences in proliferation and cell-occupied volume. Finally, injection of porous HA-Tet MAP scaffolds into an ischemic stroke model shows this chemistry is biocompatible in vivo with reduced levels of inflammation and astrogliosis as previously demonstrated for other crosslinking chemistries.
Subject(s)
Hydrogels , Regenerative Medicine , Biocompatible Materials , Fibroblasts , Humans , Hyaluronic Acid , Porosity , Tissue Engineering , Tissue ScaffoldsABSTRACT
Despite ongoing advancements in the field of medicine, glioblastoma multiforme (GBM) is presently incurable, making this advanced brain tumor the deadliest tumor type in the central nervous system. The primary treatment strategies for GBM (i.e. surgical resection, radiation therapy, chemotherapy, and newly incorporated targeted therapies) fail to overcome the challenging characteristics of highly aggressive GBM tumors and are presently given with the goal of increasing the quality of life for patients. With the aim of creating effective treatment solutions, research has shifted toward utilizing injectable biomaterial adjuncts to minimize invasiveness of treatment, provide spatiotemporal control of therapeutic delivery, and engage with cells through material-cell interfaces. This review aims to summarize the limitations of the current standard of care for GBM, discuss how these limitations can be addressed by local employment of injectable biomaterial systems, and highlight developments in the field of biomaterials for these applications.